品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

yesbiotech/mAb anti-Human CD71 Transferrin Receptor, CY-TFR/0.1 mg/MO-L40042

价格
¥3600.00
货号:MO-L40042
浏览量:127
品牌:yesbiotech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Description
  • Additional

Description

Details

Description:Mouse monoclonal antibody (mAb) to human transferrin receptor or mAb to human cluster of differentiation 71 (CD71).

Purification:Protein G affinity purified

Product Type:Primary antibody

Target Protein:Human transferrin receptor

Immunogen:Purified human transferrin receptor

Fusion Myeloma:Sp2/0-Ag14

Specificity:Reactive with human transferrin receptor.

Species Reactivity:Human, others not tested.

Host / Isotype:Mouse, IgG1 Kappa

Formulation:Lyophilized from a solution in 0.01M PBS, pH 7.2

Reconstitution:Double distilled water is recommended to adjust the final concentration to 1.00mg/mL.

Storage: Store at -20oC

Research Area:Iron metabolism

Background:

Transferrin receptor, also known as CD71 or p90, is expressed at the surface of cells that utilize iron. The receptor binds transferrin and internalizes iron carried with it. Like many other proteins involved with iron metabolism, transferrin receptor is regulated by iron response element-binding proteins (IRE-BPs). Transferrin receptor is highly expressed in erythroid cells, placental tissue, and rapidly dividing cells. When iron concentration in the cells is low,IRE-BPs bind to the IREs on the mRNA of transferrin receptor to increase the transcription of the receptor.

Transferrin receptors in macrophage, T-cells and B lymphocyte are increased during activation.

Application:ELISA

References:

If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.

Additional

Additional Information

Product SpecificitymAb anti-Human CD71 Transferrin Receptor, CY-TFR
ApplicationEIA
Size0.1 mg
yesbiotech自2009年以来,我们一直在开发针对AD的基于抗体的疗法,并针对多种淀粉样β(Aβ)肽产生了70多种单克隆抗体(mAb)。这些单克隆抗体中的三个(3F5、6C8和1H3)已显示出在小鼠模型中预防AD进展的功效。我们还开发了一种ELISA试剂盒,用于定量测量AD的主要病因Aβ42。我们的AD前项目是首次尝试通过鼻内途径将抗Aβ42单抗用于AD预防和治疗。